MJBizDaily
Medical cannabis dispensary rejected for DEA registration as more federal marijuana rescheduling details emerge
Featured
Latest Posts
Federal hemp rules threaten 225,000 jobs and $8.9 billion in wages
A federal ban on intoxicating hemp products expected to take effect Dec. 11 threatens to reduce retail revenue by $28.3 billion.
News September 10
Trump medical marijuana rescheduling order survives initial challenge
But the ruling doesn't close out a legal challenge to marijuana rescheduling.
News September 10
Why cannabis growers are locking in harvest labor now
Croptober drives cannabis hiring to its yearly peak, with Vangst issuing 10,000 W2s.
News September 10
Missouri moves intoxicating hemp into regulated cannabis market Nov. 12
Anything over 0.4 milligrams of THC per container becomes marijuana, sellable only in licensed stores and grown in state-licensed facilities.
News September 9
Campaign to criminalize Massachusetts cannabis sales heavily outspending opposition
The national anti-marijuana group behind the push to outlaw the $1.65 billion annual Massachusetts cannabis industry is outspending the industry significantly.
News September 9
Can South Africa challenge Canada for global cannabis export dominance?
Canadian companies still dominate global cannabis exports, but a new challenger is emerging: South Africa, where producers are confident they can compete on quality and standards and not just price.
News September 9
Ohio cannabis store voluntarily closes as state investigates ‘serious health events’
An Arizona-based cannabis multistate operator closed an Ohio cannabis store after learning that state regulators are investigating at least two serious adverse health problems suffered by suspected customers.
News September 8
Delaware cannabis sales hit record in July, trail projections
Licensing delays have stalled the launch of retail-only stores, while high prices and limited options drive buyers to neighboring states.
News September 8
Why a cannabis business is betting on dogs to reach FDA approval
Endovia is pursuing FDA veterinary approval for its cannabinoid drug targeting canine cancer and chronic pain in the companion-animal market.
News September 8
Latest Sponsored
